Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants

Journal of Pediatrics

Volumn 129, Issue 5, 1996, Pages 695-701

  Schmitt, H J ^a   Schuind, A ^a   Knuf, M ^a   Beutel, K ^a   Schulte Wissermann, H ^a   Gahr, M ^a   Schult, R ^a   Folkens, J ^a   Rauh, W ^a   Bogaerts, H ^a   Bork, H L ^a   Clemens, R ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID;

ARTICLE; DIPHTHERIA; DRUG SAFETY; DRUG TOLERANCE; GERMANY; HUMAN; IMMUNOGENICITY; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PERTUSSIS; PRIORITY JOURNAL; TETANUS; VACCINATION;

EID: 0030377431     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70152-X     Document Type: Article

References (30)

1. JD. Cherry The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study Curr Probl Pediatr 14 1984 1 78
2. V Romanus R Jonsell S-O. Bergquist Pertussis in Sweden after the cessation of general immunization in 1979 Pediatr Infect Dis J 6 1987 364 371
3. GR Noble RH Bernier EC Esber C Hardegree AR Hinman D Klein Acellular and whole-cell pertussis vaccines in Japan: report of a visit by U.S. scientists JAMA 257 1987 1351 1356
4. H Finger CH Wirsing von Konig A Tacken SGF. Wassilak The epidemiological situation of pertussis in the Federal Republic of Germany Dev Biol Stand 73 1991 343 355
5. Y Sato M Kimura H. Fukumi Development of a pertussis component vaccine in Japan Lancet 1 1984 122 126
6. KM. Edwards Acellular pertussis vaccines-a solution to the pertussis problem? J Infect Dis 168 1993 15 20
7. KM Edwards DT. Karzon The search for an improved pertussis vaccine Pediatr Ann 19 1990 695 701
8. DA Blumberg CM Mink JD. Cherry Comparison of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants J Pediatr 119 1991 194 204
9. S Wiersbitzky H Boch R Bruns R Clemens G Graul H Köditz Verträglichkeit und Immunogenität einer Drei- Komponentenazellulären-Pertussis-Vakzine (DTPa) im Vergleich zur klassischen DTPg Vakzine Monatsschr Kinderheilkd 2 1995 159 166
10. H-J Schmitt CH Wirsing von König A Neiss Efficacy of acellular pertussis vaccine in early childhood after household exposure JAMA 275 1996 37 41
11. European Community Commission Directive 91/507/EEC 1991
12. O Ruuskanen A Noel A Putto-Laurila Development of an acellular pertussis vaccine and its administration as a booster in healthy adults Vaccine 9 1991 117 121
13. G Kanra M Ceyhan D Vandevoorde H. Bogaerts Acellular pertussis diphtheria-tetanus pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children Eur J Pediatr 152 1993 478 483
14. J Van Savage MD Decker KM Edwards SH Sell DT. Karzon Natural history of pertussis antibody in the infant and the effect of vaccine response J Infect Dis 161 1990 487 492
15. ME Camargo L Silveira JA Furuta EPT Oliveira OA. Germak Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum J Clin Microbiol 20 1984 772 774
16. M Melville-Smith V Seagroatt J. Watkins A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralisation test in mice as a method for the estimation of tetanus antitoxin in human sera J Biol Stand 11 1983 13744
17. D Machin J. Campbell Statistical tables for the design of clinical trials [Table 6.1] 1987 Blackwell Scientific Publications Oxford 65
18. ME Pichichero C Christy MD Decker Defining the key parameters for comparing reactions among acellular and whole-cell pertussis vaccines Pediatrics 96 Suppl 1995 588 592
19. G Jorch S Schmidt-Troschke T Bajanowski Epidemiologische Risikofaktoren des plötzlichen Kindstods Monatsschr Kinderheilkd 142 1994 45 51
20. GS. Golden Pertussis vaccine and injury to the brain J Pediatr 116 1990 854 861
21. DL Miller EM Ross R Alderslade MH Bellman NSB. Rawson Pertussis immunisation and serious acute neurological illness in children Br Med J 282 1981 1595 1599
22. K Stehr U. Heininger Aktueller Stand der Keuchhustenschutzimpfung Padiatr Prax 42 1991 391 402
23. S Ohtahara Y Ohtsuka Y Yamatogi E Oka H Yoshinaga M. Sato Prenatal etiologies of West syndrome Epilepsia 34 1993 716 722
24. JD Cherry AE Holtzman WD Shields Pertussis immunization and characteristics related to first seizures in infants and children J Pediatr 122 1993 900 903
25. CL Cody LJ Baraff JD Cherry SM Marcy CR. Manclark Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children Pediatrics 68 1981 650 660
26. M Kimura H Kuno-Sakai Y Sato H Kamiya R Nii S Isomura A comparative trial of the reactogenicity and immunogenicity of Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids Am J Dis Child 145 1991 734 741
27. H Kamiya R Nii T Matsuda N Yasuda PD Christenson JD. Cherry Immunogenicity and reactogenicity of Takeda acellular pertussis-component diphtheria-tetanus-pertussis vaccine in 2- and 3-month-old children in Japan Am J Dis Child 146 1992 1141 1147
28. R Booy SJM Aitken S Taylor G Tudor-Williams JA MacFarlane RE Moxon Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age Lancet 339 1992 507 510
29. J Storsaeter WC Blackwelder HO. Hallander Pertussis antibodies, protection, and vaccine efficacy after household exposure Am J Dis Child 146 1992 167 172
30. D Greco S Salmaso P Mastrantonio A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis N Engl J Med 334 1996 341 348